Myostatin Levels in SMA Following Disease‐Modifying Treatments: A Multi‐Center Study

Myostatin Levels in SMA Following Disease‐Modifying Treatments: A Multi‐Center Study

ABSTRACT Objective This study investigated myostatin levels in SMA patients receiving disease‐modifying therapies (DMTs) to understand their relationship with treatment duration and functional status. Methods Our study includes both cross‐sectional and longitudinal analyses of myostatin levels in tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Fiorella Piemonte, Sara Petrillo, Anna Capasso, Giorgia Coratti, Adele D'Amico, Michela Catteruccia, Maria Carmela Pera, Concetta Palermo, Marika Pane, Emanuela Abiusi, Gianpaolo Cicala, Marianna Villa, Chiara Bravetti, Chiara Arpaia, Agnese Novelli, Salvatore Falqui, Stefania Fiori, Giulia Napoli, Silvia Baroni, Francesco Danilo Tiziano, Enrico Bertini, Giacomo Comi, Stefania Corti, Eugenio Mercuri
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Annals of Clinical and Translational Neurology
Subjects:
biomarkers
disease‐modifying therapies
myostatin
neuromuscular disorders
spinal muscular atrophy
treatment response
Online Access:https://doi.org/10.1002/acn3.70070
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://doi.org/10.1002/acn3.70070

Similar Items